Table 3 of García-García, Mol Vis 2013; 19:367-373.

Table 3. Clinical description of the patients bearing mutations in GPR98.

Patient Sensorineural hearing loss Vestibular function Onset of night blindness Onset of visual field loss Visual field Visual acuity Eye fundus ERG Cataracts
RP1068 moderate since 7 years Normal 30 - Marked Concentric Loss 0.25/0.25 (at 34 years) 1 - BE
RP1157 moderate-severe ? 11 - Marked Concentric Loss 0.16/0.16 (2010) 1 Abolish (37 years) BE
RP1188 moderate since 1 year Normal 17 16 0.5/1 (2002) 1 - No
RP153 moderate-severe Normal 16 - Marked Concentric Loss - 1 - BE
RP952 moderate since 4 years Normal 25 35 Moderate Concentric Loss (at 45 years) 0.7/0.7 (at 45 years) 1 Abolish BE

Onset of night blindness and visual field loss are expressed in years. Eye fundus 1: Bone spicule deposits, attenuation of vessels, and pale optic nerve. ERG: Electroretinography. BE: Both Eyes. No clinical description is available for patients RP1590 and RP1634.

García-García, Mol Vis 2013; 19:367-373. http://www.molvis.org/molvis/v19/367

©2013 Molecular Vision http://www.molvis.org/molvis/

ISSN 1090-0535